208 related articles for article (PubMed ID: 22787556)
1. Carcinogenicity evaluation for the application of carbon nanotubes as biomaterials in rasH2 mice.
Takanashi S; Hara K; Aoki K; Usui Y; Shimizu M; Haniu H; Ogihara N; Ishigaki N; Nakamura K; Okamoto M; Kobayashi S; Kato H; Sano K; Nishimura N; Tsutsumi H; Machida K; Saito N
Sci Rep; 2012; 2():498. PubMed ID: 22787556
[TBL] [Abstract][Full Text] [Related]
2. Organ accumulation and carcinogenicity of highly dispersed multi-walled carbon nanotubes administered intravenously in transgenic rasH2 mice.
Sobajima A; Haniu H; Nomura H; Tanaka M; Takizawa T; Kamanaka T; Aoki K; Okamoto M; Yoshida K; Sasaki J; Ajima K; Kuroda C; Ishida H; Okano S; Ueda K; Kato H; Saito N
Int J Nanomedicine; 2019; 14():6465-6480. PubMed ID: 31616140
[TBL] [Abstract][Full Text] [Related]
3. Pathological features of spontaneous and induced tumors in transgenic mice carrying a human prototype c-Ha-ras gene used for six-month carcinogenicity studies.
Mitsumori K; Koizumi H; Nomura T; Yamamoto S
Toxicol Pathol; 1998; 26(4):520-31. PubMed ID: 9715511
[TBL] [Abstract][Full Text] [Related]
4. Review of toxicity studies of carbon nanotubes.
Kobayashi N; Izumi H; Morimoto Y
J Occup Health; 2017 Sep; 59(5):394-407. PubMed ID: 28794394
[TBL] [Abstract][Full Text] [Related]
5. The carcinogenic effect of various multi-walled carbon nanotubes (MWCNTs) after intraperitoneal injection in rats.
Rittinghausen S; Hackbarth A; Creutzenberg O; Ernst H; Heinrich U; Leonhardt A; Schaudien D
Part Fibre Toxicol; 2014 Nov; 11():59. PubMed ID: 25410479
[TBL] [Abstract][Full Text] [Related]
6. Toxicity of multiwalled carbon nanotubes with end defects critically depends on their functionalization density.
Jain S; Thakare VS; Das M; Godugu C; Jain AK; Mathur R; Chuttani K; Mishra AK
Chem Res Toxicol; 2011 Nov; 24(11):2028-39. PubMed ID: 21978239
[TBL] [Abstract][Full Text] [Related]
7. Systemic and immunotoxicity of pristine and PEGylated multi-walled carbon nanotubes in an intravenous 28 days repeated dose toxicity study.
Zhang T; Tang M; Zhang S; Hu Y; Li H; Zhang T; Xue Y; Pu Y
Int J Nanomedicine; 2017; 12():1539-1554. PubMed ID: 28280324
[TBL] [Abstract][Full Text] [Related]
8. The Tg rasH2 mouse in cancer hazard identification.
Morton D; Alden CL; Roth AJ; Usui T
Toxicol Pathol; 2002; 30(1):139-46. PubMed ID: 11890467
[TBL] [Abstract][Full Text] [Related]
9. Toxicity of functionalized multi-walled carbon nanotubes on bone mesenchymal stem cell in rats.
Song G; Guo X; Zong X; DU L; Zhao J; Lai C; Jin X
Dent Mater J; 2019 Feb; 38(1):127-135. PubMed ID: 30449827
[TBL] [Abstract][Full Text] [Related]
10. [Evaluations of the Carcinogenicity of Carbon Nanotubes, Fluoro-Edinite, and Silicon Carbide by the International Agency for Research on Cancer (IARC)].
Morimoto Y; Kobayashi N
Nihon Eiseigaku Zasshi; 2016; 71(3):252-259. PubMed ID: 27725428
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of the clastogenicity of functionalized and nonfunctionalized multiwalled carbon nanotubes in bone marrow cells of Swiss-Webster mice.
Patlolla AK; Hussain SM; Schlager JJ; Patlolla S; Tchounwou PB
Environ Toxicol; 2010 Dec; 25(6):608-21. PubMed ID: 20549644
[TBL] [Abstract][Full Text] [Related]
12. Rapid induction of more malignant tumors by various genotoxic carcinogens in transgenic mice harboring a human prototype c-Ha-ras gene than in control non-transgenic mice.
Yamamoto S; Mitsumori K; Kodama Y; Matsunuma N; Manabe S; Okamiya H; Suzuki H; Fukuda T; Sakamaki Y; Sunaga M; Nomura G; Hioki K; Wakana S; Nomura T; Hayashi Y
Carcinogenesis; 1996 Nov; 17(11):2455-61. PubMed ID: 8968063
[TBL] [Abstract][Full Text] [Related]
13. Examination of percutaneous application in a 26-week carcinogenicity test in CB6F1-TG rasH2 mice.
Urano K; Suzuki S; Machida K; Eguchi N; Sawa N; Kikuchi K; Hattori Y; Usui T
J Toxicol Sci; 2007 Oct; 32(4):367-75. PubMed ID: 17965551
[TBL] [Abstract][Full Text] [Related]
14. Genotoxicity and carcinogenicity risk of carbon nanotubes.
Toyokuni S
Adv Drug Deliv Rev; 2013 Dec; 65(15):2098-110. PubMed ID: 23751780
[TBL] [Abstract][Full Text] [Related]
15. Validation of transgenic mice carrying the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing.
Yamamoto S; Urano K; Koizumi H; Wakana S; Hioki K; Mitsumori K; Kurokawa Y; Hayashi Y; Nomura T
Environ Health Perspect; 1998 Feb; 106 Suppl 1(Suppl 1):57-69. PubMed ID: 9539005
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of biocompatible dispersants for carbon nanotube toxicity tests.
Kim JS; Song KS; Lee JH; Yu IJ
Arch Toxicol; 2011 Dec; 85(12):1499-508. PubMed ID: 21656221
[TBL] [Abstract][Full Text] [Related]
17. Carbon nanotube-based biomaterials for orthopaedic applications.
Aoki K; Ogihara N; Tanaka M; Haniu H; Saito N
J Mater Chem B; 2020 Oct; 8(40):9227-9238. PubMed ID: 32935730
[TBL] [Abstract][Full Text] [Related]
18. A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks.
Lam CW; James JT; McCluskey R; Arepalli S; Hunter RL
Crit Rev Toxicol; 2006 Mar; 36(3):189-217. PubMed ID: 16686422
[TBL] [Abstract][Full Text] [Related]
19. Twenty-six-week oral carcinogenicity study of 3-monochloropropane-1,2-diol in CB6F1-rasH2 transgenic mice.
Lee BS; Park SJ; Kim YB; Han JS; Jeong EJ; Son HY; Moon KS
Arch Toxicol; 2017 Jan; 91(1):453-464. PubMed ID: 27017489
[TBL] [Abstract][Full Text] [Related]
20. Twenty-six-week carcinogenicity study of sulfamethoxazole in CB6F1-Tg-rasH2 mice.
Torii M; Itoh F; Yabuuchi K; Ohno K; Kominami G; Hirano K; Tasaki T; Nara H
J Toxicol Sci; 2001 May; 26(2):61-73. PubMed ID: 11429969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
